InnovAge Beats Revenue Estimates Despite Q4 Earnings Miss

Key Facts

1InnovAge reported earnings per share of $0.06, missing the consensus estimate of $0.07.

2The company posted quarterly revenue of $261.95 million, beating analyst expectations of $238.33 million.

3Full-year revenue grew 15.9% to $989.7 million, with adjusted EBITDA surging 175% to $94.6 million.

Amid ongoing operational shifts in the healthcare sector, InnovAge Holding Corp reported mixed results for its fourth quarter and full fiscal year. The company posted earnings per share (EPS) of $0.06, missing the consensus analyst estimate of $0.07. Despite this bottom-line miss, the firm demonstrated significant top-line strength, generating quarterly revenue of $261.95 million, which comfortably exceeded the $238.33 million expected by markets.

The full-year performance highlighted a robust recovery, with total revenue growing 15.9% to $989.7 million. A key highlight was the adjusted EBITDA, which surged by 175% to reach $94.6 million, signaling improved operational efficiency. According to analyst reports, this growth stems from a successful turnaround strategy and expansion within the Program of All-Inclusive Care for the Elderly (PACE) market.

At the close of trading on September 8, 2026, INNV shares stood at $10.52, having fluctuated between a day low of $10.23 and a high of $10.68 per market data. Investors will be watching for the company's ability to convert revenue momentum into consistent profitability. Upcoming catalysts for broader market sentiment include the U.S. Initial Jobless Claims and the ISM Services PMI data scheduled for release later this week.